TY - JOUR
T1 - Understanding the Effects of Mitral Transcatheter Edge-to-Edge Repair on Left Ventricular Function Using Pressure-Volume Loops
AU - Nagueh, Sherif F.
AU - Pournazari, Payam
AU - Wessly, Priscilla
AU - Hatab, Taha
AU - Bhimaraj, Arvind
AU - Faza, Nadeen N.
AU - Little, Stephen H.
AU - Goel, Sachin S.
N1 - Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2025/3
Y1 - 2025/3
N2 - BACKGROUND: Mitral transcatheter edge-to-edge repair (M-TEER) is an effective treatment for mitral regurgitation (MR) patients.OBJECTIVES: The aim of this research was to study M-TEER effects on left atrial (LA) and left ventricular (LV) functions.METHODS: LV function was evaluated using conductance catheters for pressure volume loops in 22 patients with primary MR and a control group of 17 heart transplant recipients with normal function. LA pressures and LA operating chamber stiffness were obtained using fluid-filled catheters. MR severity was assessed by echocardiography.RESULTS: Compared to the control group, primary MR patients had increased LV volumes, diastolic pressures, tau, and LV chamber stiffness constant (all P ≤ 0.01). After M-TEER, LV and LA volumes and pressures and MR regurgitant volume decreased (all P < 0.05), without significant change in LV preload recruitable stroke work (50.7 ± 14 vs 47 ± 17 mm Hg), end systolic pressure/volume (1.67 ± 0.69 vs 1.66 ± 0.62 mm Hg/mL), pressure volume area (11,493 ± 3,428 vs 11,898 ± 5,256 mm Hg. mL), and chamber stiffness constant (0.05 ± 0.07 vs 0.03 ± 0.02, all P > 0.20). Post-M-TEER, patients with LA V wave pressure ≥20 mm Hg had significantly higher LA operating chamber stiffness, tau, and LV chamber stiffness constant vs patients with V wave pressure <20 mm Hg all (P < 0.05).CONCLUSIONS: After M-TEER, there is no significant change in invasive indices of LV contractility. Tau is significantly prolonged after M-TEER, whereas LV chamber stiffness constant is abnormally increased before M-TEER without a significant change afterward. Patients with LA "V" wave pressure ≥20 mm Hg after M-TEER have worse LV diastolic function and higher LA operating chamber stiffness.
AB - BACKGROUND: Mitral transcatheter edge-to-edge repair (M-TEER) is an effective treatment for mitral regurgitation (MR) patients.OBJECTIVES: The aim of this research was to study M-TEER effects on left atrial (LA) and left ventricular (LV) functions.METHODS: LV function was evaluated using conductance catheters for pressure volume loops in 22 patients with primary MR and a control group of 17 heart transplant recipients with normal function. LA pressures and LA operating chamber stiffness were obtained using fluid-filled catheters. MR severity was assessed by echocardiography.RESULTS: Compared to the control group, primary MR patients had increased LV volumes, diastolic pressures, tau, and LV chamber stiffness constant (all P ≤ 0.01). After M-TEER, LV and LA volumes and pressures and MR regurgitant volume decreased (all P < 0.05), without significant change in LV preload recruitable stroke work (50.7 ± 14 vs 47 ± 17 mm Hg), end systolic pressure/volume (1.67 ± 0.69 vs 1.66 ± 0.62 mm Hg/mL), pressure volume area (11,493 ± 3,428 vs 11,898 ± 5,256 mm Hg. mL), and chamber stiffness constant (0.05 ± 0.07 vs 0.03 ± 0.02, all P > 0.20). Post-M-TEER, patients with LA V wave pressure ≥20 mm Hg had significantly higher LA operating chamber stiffness, tau, and LV chamber stiffness constant vs patients with V wave pressure <20 mm Hg all (P < 0.05).CONCLUSIONS: After M-TEER, there is no significant change in invasive indices of LV contractility. Tau is significantly prolonged after M-TEER, whereas LV chamber stiffness constant is abnormally increased before M-TEER without a significant change afterward. Patients with LA "V" wave pressure ≥20 mm Hg after M-TEER have worse LV diastolic function and higher LA operating chamber stiffness.
KW - diastolic function
KW - left atrium
KW - left ventricle
KW - mitral regurgitation
KW - transcatheter edge to edge repair
UR - http://www.scopus.com/inward/record.url?scp=85217938035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217938035&partnerID=8YFLogxK
U2 - 10.1016/j.jacadv.2025.101627
DO - 10.1016/j.jacadv.2025.101627
M3 - Article
C2 - 39983617
AN - SCOPUS:85217938035
SN - 2772-963X
VL - 4
SP - 101627
JO - JACC: Advances
JF - JACC: Advances
IS - 3
M1 - 101627
ER -